Correlation Between SAB Biotherapeutics and Senti Biosciences

Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Senti Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Senti Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SAB Biotherapeutics and Senti Biosciences, you can compare the effects of market volatilities on SAB Biotherapeutics and Senti Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Senti Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Senti Biosciences.

Diversification Opportunities for SAB Biotherapeutics and Senti Biosciences

0.37

Correlation Coefficient

SAB Biotherapeutics  Senti Biosciences

Weak diversification

The 3 months correlation between SAB and Senti is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Senti Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Senti Biosciences and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Senti Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Senti Biosciences has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Senti Biosciences go up and down completely randomly.

Pair Corralation between SAB Biotherapeutics and Senti Biosciences

Given the investment horizon of 90 days SAB Biotherapeutics is expected to generate 2.12 times more return on investment than Senti Biosciences. However, SAB Biotherapeutics is 2.12 times more volatile than Senti Biosciences. It trades about 0.04 of its potential returns per unit of risk. Senti Biosciences is currently generating about -0.13 per unit of risk. If you would invest  196.00  in SAB Biotherapeutics on July 6, 2025 and sell it today you would earn a total of  10.00  from holding SAB Biotherapeutics or generate 5.1% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

SAB Biotherapeutics  vs.  Senti Biosciences

SAB Biotherapeutics

Risk-Adjusted Performance

Soft

Compared to the overall equity markets, risk-adjusted returns on investments in SAB Biotherapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively abnormal fundamental drivers, SAB Biotherapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Senti Biosciences

Risk-Adjusted Performance

Weakest

Over the last 90 days Senti Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in November 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pair Trading with SAB Biotherapeutics and Senti Biosciences

The main advantage of trading using opposite SAB Biotherapeutics and Senti Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Senti Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Senti Biosciences will offset losses from the drop in Senti Biosciences' long position.

The idea behind SAB Biotherapeutics and Senti Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.